N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide

C135H150F3N31O6 — CID 158827383

IUPACN-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide
SMILESCN(C)CCN(C)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1.CN(C)Cc1cccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)c1.CN1CCC(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)CC1.C[C@@H]1CCC[C@H](C)N1Cc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccc(C#N)cc4)c3c2)c1.O=C(Nc1ccc(C(F)(F)F)cc1)c1n[nH]c2ccc(-c3cncc(CN4CCOCC4)c3)cc12
InChIInChI=1S/C29H36N8O.C28H28N6O.C28H32N6O.C25H22F3N5O2.C25H32N6O/c1-35(2)13-14-36(3)27-10-8-24(19-31-27)32-29(38)28-25-16-22(7-9-26(25)33-34-28)23-15-21(17-30-18-23)20-37-11-5-4-6-12-37;1-18-4-3-5-19(2)34(18)17-21-12-23(16-30-15-21)22-8-11-26-25(13-22)27(33-32-26)28(35)31-24-9-6-20(14-29)7-10-24;1-33(2)18-20-7-6-8-24(14-20)30-28(35)27-25-15-22(9-10-26(25)31-32-27)23-13-21(16-29-17-23)19-34-11-4-3-5-12-34;26-25(27,28)19-2-4-20(5-3-19)30-24(34)23-21-12-17(1-6-22(21)31-32-23)18-11-16(13-29-14-18)15-33-7-9-35-10-8-33;1-30-11-7-21(8-12-30)27-25(32)24-22-14-19(5-6-23(22)28-29-24)20-13-18(15-26-16-20)17-31-9-3-2-4-10-31/h7-10,15-19H,4-6,11-14,20H2,1-3H3,(H,32,38)(H,33,34);6-13,15-16,18-19H,3-5,17H2,1-2H3,(H,31,35)(H,32,33);6-10,13-17H,3-5,11-12,18-19H2,1-2H3,(H,30,35)(H,31,32);1-6,11-14H,7-10,15H2,(H,30,34)(H,31,32);5-6,13-16,21H,2-4,7-12,17H2,1H3,(H,27,32)(H,28,29)/t;18-,19+;;;
InChIKeyIWPUUHREZLNRGA-LKTAWHQWSA-N
MW2359.89 g/mol
LogP22.86
Rot. Bonds31

About N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide

N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide (PubChem CID 158827383) has the molecular formula C135H150F3N31O6 and a molecular weight of 2359.89 g/mol. Its IUPAC name is N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide.

Molecular Properties

Compound NameN-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide
PubChem CID158827383
Molecular FormulaC135H150F3N31O6
Molecular Weight2359.89 g/mol
Exact Mass2358.23
IUPAC NameN-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide
SMILESCN(C)CCN(C)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1.CN(C)Cc1cccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)c1.CN1CCC(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)CC1.C[C@@H]1CCC[C@H](C)N1Cc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccc(C#N)cc4)c3c2)c1.O=C(Nc1ccc(C(F)(F)F)cc1)c1n[nH]c2ccc(-c3cncc(CN4CCOCC4)c3)cc12
InChIInChI=1S/C29H36N8O.C28H28N6O.C28H32N6O.C25H22F3N5O2.C25H32N6O/c1-35(2)13-14-36(3)27-10-8-24(19-31-27)32-29(38)28-25-16-22(7-9-26(25)33-34-28)23-15-21(17-30-18-23)20-37-11-5-4-6-12-37;1-18-4-3-5-19(2)34(18)17-21-12-23(16-30-15-21)22-8-11-26-25(13-22)27(33-32-26)28(35)31-24-9-6-20(14-29)7-10-24;1-33(2)18-20-7-6-8-24(14-20)30-28(35)27-25-15-22(9-10-26(25)31-32-27)23-13-21(16-29-17-23)19-34-11-4-3-5-12-34;26-25(27,28)19-2-4-20(5-3-19)30-24(34)23-21-12-17(1-6-22(21)31-32-23)18-11-16(13-29-14-18)15-33-7-9-35-10-8-33;1-30-11-7-21(8-12-30)27-25(32)24-22-14-19(5-6-23(22)28-29-24)20-13-18(15-26-16-20)17-31-9-3-2-4-10-31/h7-10,15-19H,4-6,11-14,20H2,1-3H3,(H,32,38)(H,33,34);6-13,15-16,18-19H,3-5,17H2,1-2H3,(H,31,35)(H,32,33);6-10,13-17H,3-5,11-12,18-19H2,1-2H3,(H,30,35)(H,31,32);1-6,11-14H,7-10,15H2,(H,30,34)(H,31,32);5-6,13-16,21H,2-4,7-12,17H2,1H3,(H,27,32)(H,28,29)/t;18-,19+;;;
InChIKeyIWPUUHREZLNRGA-LKTAWHQWSA-N
XLogP22.86
TPSA428.42 Ų
H-Bond Donors10
H-Bond Acceptors27
Rotatable Bonds31
Heavy Atoms175
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002359.89
LogP ≤ 522.86
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1027

Analyze N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide?
The IUPAC name of N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide (CID 158827383) is N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide.
What is the SMILES notation for N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide?
The canonical SMILES for N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide is CN(C)CCN(C)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1.CN(C)Cc1cccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)c1.CN1CCC(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)CC1.C[C@@H]1CCC[C@H](C)N1Cc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccc(C#N)cc4)c3c2)c1.O=C(Nc1ccc(C(F)(F)F)cc1)c1n[nH]c2ccc(-c3cncc(CN4CCOCC4)c3)cc12.
What is the InChIKey of N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide?
The InChIKey is IWPUUHREZLNRGA-LKTAWHQWSA-N. The full InChI is InChI=1S/C29H36N8O.C28H28N6O.C28H32N6O.C25H22F3N5O2.C25H32N6O/c1-35(2)13-14-36(3)27-10-8-24(19-31-27)32-29(38)28-25-16-22(7-9-26(25)33-34-28)23-15-21(17-30-18-23)20-37-11-5-4-6-12-37;1-18-4-3-5-19(2)34(18)17-21-12-23(16-30-15-21)22-8-11-26-25(13-22)27(33-32-26)28(35)31-24-9-6-20(14-29)7-10-24;1-33(2)18-20-7-6-8-24(14-20)30-28(35)27-25-15-22(9-10-26(25)31-32-27)23-13-21(16-29-17-23)19-34-11-4-3-5-12-34;26-25(27,28)19-2-4-20(5-3-19)30-24(34)23-21-12-17(1-6-22(21)31-32-23)18-11-16(13-29-14-18)15-33-7-9-35-10-8-33;1-30-11-7-21(8-12-30)27-25(32)24-22-14-19(5-6-23(22)28-29-24)20-13-18(15-26-16-20)17-31-9-3-2-4-10-31/h7-10,15-19H,4-6,11-14,20H2,1-3H3,(H,32,38)(H,33,34);6-13,15-16,18-19H,3-5,17H2,1-2H3,(H,31,35)(H,32,33);6-10,13-17H,3-5,11-12,18-19H2,1-2H3,(H,30,35)(H,31,32);1-6,11-14H,7-10,15H2,(H,30,34)(H,31,32);5-6,13-16,21H,2-4,7-12,17H2,1H3,(H,27,32)(H,28,29)/t;18-,19+;;;.
What are the key properties of N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide?
N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide has a molecular weight of 2359.89 g/mol, XLogP of 22.86, 31 rotatable bonds, 10 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-cyanophenyl)-5-[5-[[(2S,6R)-2,6-dimethylpiperidin-1-yl]methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[3-[(dimethylamino)methyl]phenyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(1-methylpiperidin-4-yl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide is sourced from PubChem (CID 158827383), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).